Past exam of the zoology course of the University of Cambridge / 2025 / Paper zl6 / 3

Epithelial cell fate plasticity is a context-dependent change in developmental potential or differentiated identity. It includes dedifferentiation toward a progenitor cell state, transdifferentiation between differentiated identities, and reversible intermediate states. It is distinct from selecting a pre-existing rare stem cell, and from ordinary progression down a lineage. epithelial-mesenchymal plasticity is one important form, but changing epithelial subtype without losing epithelial organization is also cell fate plasticity.

The strongest physiological rationale is that a tissue needs both stable specialization and reserve routes for replacement. During ordinary adult tissue homeostasis, a stem-cell hierarchy can efficiently supply predictable cell types. After injury removes a component of that hierarchy, local signals and newly available stem-cell niche space may permit a committed descendant to reacquire self-renewal. In mouse intestine, Alpi marked enterocyte-lineage progenitor cells normally generate short-lived absorptive descendants. After targeted ablation of Lgr5 positive intestinal stem cells, labelled progenitor cells can generate long-lived crypt-villus lineages with renewed stem-cell output. Comparing the same labelled population before and after ablation distinguishes injury-dependent cell fate plasticity from its normal fate. The experiment concerns progenitor cells in the enterocyte lineage; it should not be generalized to every terminally mature villus enterocyte.^[ref]

A complementary model is the mouse airway. Genetic depletion of basal stem cells, combined with prior lineage tracing of luminal secretory cells, revealed secretory-cell descendants that acquired basal-cell properties and sustained subsequent epithelial production. Experiments with isolated cells and cocultures further showed that contact with basal cells inhibits this conversion. cell fate plasticity is therefore regulated by the tissue environment, not simply an intrinsic capacity unmasked whenever a marker changes. Its interpretation requires controls for residual basal cells and for whether the secretory-lineage driver labelled basal cells before injury.^[ref]

Development provides additional contexts. Embryonic epithelia can undergo epithelial-to-mesenchymal transition during processes such as gastrulation, and mesenchymal-to-epithelial transition can subsequently assemble epithelial structures. These are regulated changes in adhesion, cell polarity, motility and gene expression, rather than a simple binary switch read from E-cadherin alone. In wound repair, transient relaxation of epithelial organization can facilitate migration while retaining intercellular contacts. A partially migratory repair state need not entail a complete mesenchymal conversion or a permanent change of lineage. Following wound closure, restoration of barrier function and polarized architecture is as important as the initial ability to move.

The most convincing experimental design labels a defined starting population irreversibly before the inducing event, allows the inducer to clear, then follows labelled descendants through the transition. Check immediate labelling specificity, include no-inducer and uninjured controls, quantify labelling efficiency and rule out ectopic driver activation after injury. Demonstrate the new state with multiple markers, morphology and function, and persistence after the inducing signal is removed. Serial epithelial production or a second injury challenge tests stable self-renewal; a transient appearance of a basal marker does not. Sparse labelling and continuous live-cell imaging help distinguish conversion from contamination, cell fusion or selective expansion of a rare initially unrecognized progenitor cell.

single-cell RNA sequencing can identify intermediate cell states and candidate regulators, but inferred trajectories are not lineage histories. Combine it with genetic barcodes, spatial localization and timed perturbation of candidate transcription factors or niche signals. Organoids offer defined media, prospective cell isolation and manipulation of matrix stiffness. A sorted population's ability to make a structure in culture establishes potential under those conditions; dissociation and a permissive medium may induce a capacity rarely used in vivo. Compare culture results with intact-tissue fate mapping before claiming a normal physiological contribution.

The evolutionary argument is a trade-off, rather than a claim that every plastic response is an adaptation. Conditional access to alternative cell fates could buffer environmental injury and permit repair without maintaining a separate reserve stem-cell pool for every possible lesion. Conserved signalling modules can also be redeployed in new developmental contexts. These advantages must be weighed against loss of specialized function, energetic costs and the danger of inappropriate persistent growth. Comparative experiments should ask whether homologous lineages undergo similar transitions under comparable injuries; shared expression of a few regulators is insufficient to prove that an ancestral cell fate plasticity programme has been conserved. At the tissue level, cell fate plasticity supplies alternative states on which selection can act, but it does not itself establish heritable evolutionary change.

Clinically, controlled cell fate plasticity may improve epithelial repair, provide transplantable cells and make patient-derived disease models. The same capacity can undermine treatment: a tumour may switch to a less drug-sensitive lineage or regenerate a stem-like population after therapy. In carcinoma, epithelial-mesenchymal plasticity can contribute to invasion and treatment resistance, but neither a single EMT marker nor its absence establishes the mechanism of metastasis. In a lineage-traced mouse lung-cancer model, the tested EMT programme was dispensable for lung metastasis while contributing to chemoresistance; the conclusion is specific to that model and reporter coverage.^[ref] The useful clinical aim is therefore a defined, reversible transition that restores function, with evidence that it does not leave a persistently proliferative or malignant population.

reactive oxygen species can alter competitive fitness, but neither high ROS nor an antioxidant response universally identifies a loser. cell competition is relative: cells that survive in one neighbourhood are preferentially lost in another, with fitter neighbours occupying their place. An experiment showing oxidant-induced death in a homogeneous tissue establishes toxicity, not necessarily cell competition. In epithelia, loss can occur through apoptosis, extrusion or differentiation followed by departure from a proliferative layer.

reactive oxygen species include superoxide and hydrogen peroxide, which differ in reactivity, localization and transport. They can arise from mitochondrial metabolism or regulated oxidase activity. At controlled levels they participate in redox signalling; excess or poorly buffered production damages DNA, proteins and membranes. Competitive fitness can therefore change through altered damage, stress responses, growth or differentiation. NRF2 and its fly counterpart CncC regulate antioxidant and detoxification programmes. Their activation is an integrated response to cellular conditions, not a direct quantitative measurement of one ROS species.

An instructive fly study compared prospective losers carrying a ribosomal-protein defect or loss of Mahjong protein. Both activated antioxidant-response genes before elimination. In ribosomal-protein-deficient cells, two ROS dyes did not reveal a uniform increase, whereas reduced-thiol staining was lower. Mild CncC activation was tolerated across an entire disc but caused boundary-enriched death in clones surrounded by normal cells; those clones survived better among less-fit neighbours. Conversely, reducing CncC impaired stressed-cell survival. Thus a protective response can also confer relative loser status. The study separated this module from JNK signalling effects on growth and from JAK-STAT signalling effects on tissue expansion; it did not establish a compulsory linear chain from ROS through JNK to elimination.^[ref]

This distinction prevents two errors. First, a high antioxidant-response reporter can coexist with successful buffering and relatively low measured oxidant levels. Second, knocking down a protective factor may kill cells autonomously, making their apparent competitive loss worse even if that factor also participates in neighbour-dependent recognition. To identify a competitive mechanism, compare the same genotype in a homogeneous tissue, in a mosaic with normal neighbours and in a mosaic with an alternative neighbour genotype. Quantify clone growth, death at boundaries and in centres, and replacement by neighbours, normalized to the corresponding cell numbers or areas. A clone that is small because its cells divide slowly has not necessarily been actively eliminated.

The adult mammalian oesophagus supplies a striking environmental example. In transgenic mouse epithelium, low-dose ionizing radiation induced an oxidative response that shifted normal basal cells toward differentiation. Cells carrying mutant p53 were relatively insensitive and expanded at their neighbours' expense. Combining antioxidant treatment with irradiation reversed the population outcome, promoting normal-cell proliferation and mutant-cell differentiation. The selective advantage was consequently conditional on the redox environment, not a fixed property of the mutation. This also shows that competitive replacement need not be executed primarily by apoptosis.^[ref]

A separate mouse experiment generated a mosaic of NRF2-deficient and NRF2-intact oesophageal cells. Deficient cells persisted under unstressed conditions but accumulated damage and were preferentially lost during exposure to the carcinogen 4-nitroquinoline 1-oxide. Tumours predominantly arose from the surviving NRF2-intact population. This supports a context-dependent role for stress protection in population selection, while not proving that every disappearing cell was directly recognized and killed by a neighbour. Carcinogen detoxification and DNA damage are additional variables, so the experiment is not a chemically pure ROS titration.^[ref]

To test a proposed ROS mechanism in an epithelial mosaic, image a calibrated, compartment-targeted redox biosensor before clone loss, along with cell boundaries, a proliferation readout and a death or differentiation reporter. Include sensor controls for pH, expression level and dynamic range; general oxidant dyes have loading, localization and chemical-specificity limitations. Perturb the source and scavenging machinery independently and restrict the perturbation to prospective losers or winners. For example, a validated catalase manipulation tests peroxide buffering, while a source-specific perturbation tests whether that peroxide is required. A matched rescue should restore both the measured redox change and the competitive outcome. Monitor cellular energy and survival in homogeneous controls because a mitochondrial perturbation can affect fitness independently of ROS. Perturb downstream stress signalling separately to distinguish oxidant production, stress detection and execution of cell loss.

The tissue consequences can be beneficial or harmful. Elimination of damaged cells can preserve a barrier, but a stress-resistant mutant can also exploit environmental oxidants to displace normal cells. Persistent stress signals from damaged or dying cells may alter neighbour proliferation and inflammation, producing further changes in fitness. The experimentally supported conclusion is that redox state reshapes the conditions under which cells persist, differentiate or are eliminated. A universal prescription to raise ROS or administer antioxidants does not follow: the relevant species, tissue compartment, neighbour genotype and exposure history determine the direction of selection.